Targeted Therapy for Non–Small Cell Lung Cancer: First Line and Beyond

Hematology/Oncology Clinics of North America（2023）

引用 0|浏览0

暂无评分

摘要

This article provides an updated review of the management of oncogene-driven non-small cell lung cancer. The use of targeted therapies for lung cancer driven by EGFR, ALK, ROS1, RET, NTRK, HER2, BRAF, MET, and KRAS are discussed, both in the first-line setting and in the setting of acquired resistance.

查看译文

关键词

Non–small cell lung cancer,Oncogenes,Targeted therapy,Resistance

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要